{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T21:04:18Z","timestamp":1793307858496,"version":"4.5.0"},"reference-count":35,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2022,4,19]],"date-time":"2022-04-19T00:00:00Z","timestamp":1650326400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2022,4,19]],"date-time":"2022-04-19T00:00:00Z","timestamp":1650326400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cardiovasc Intervent Radiol"],"published-print":{"date-parts":[[2022,8]]},"DOI":"10.1007\/s00270-022-03149-4","type":"journal-article","created":{"date-parts":[[2022,4,19]],"date-time":"2022-04-19T18:02:58Z","timestamp":1650391378000},"page":"1141-1151","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":22,"title":["Transarterial Chemoembolization with Doxorubicin Eluting Beads for Extra-Abdominal Desmoid Tumors: Initial Experience"],"prefix":"10.1007","volume":"45","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6974-3529","authenticated-orcid":false,"given":"Daehee","family":"Kim","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mary Louise","family":"Keohan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mrinal M.","family":"Gounder","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aimee M.","family":"Crago","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joseph P.","family":"Erinjeri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,4,19]]},"reference":[{"key":"3149_CR1","unstructured":"Fletcher, C.D.M., World Health Organization., and International Agency for Research on Cancer., WHO classification of tumours of soft tissue and bone. 4th ed. World Health Organization classification of tumours. 2013, Lyon: IARC Press. 468 p"},{"issue":"2","key":"3149_CR2","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1200\/JCO.2017.75.8482","volume":"36","author":"MM Gounder","year":"2018","unstructured":"Gounder MM, Thomas DM, Tap WD. Locally aggressive connective tissue tumors. J Clin Oncol. 2018;36(2):202\u20139.","journal-title":"J Clin Oncol"},{"issue":"1","key":"3149_CR3","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1007\/s40487-016-0017-z","volume":"4","author":"JH Howard","year":"2016","unstructured":"Howard JH, Pollock RE. Intra-abdominal and abdominal wall desmoid fibromatosis. Oncol Ther. 2016;4(1):57\u201372.","journal-title":"Oncol Ther"},{"key":"3149_CR4","unstructured":"Desmoid Tumor Working, G., The management of desmoid tumours: A joint global consensus-based guideline approach for adult and paediatric patients. Eur J Cancer, 2020; 127: p. 96\u2013107."},{"issue":"10","key":"3149_CR5","doi-asserted-by":"publisher","first-page":"2399","DOI":"10.1093\/annonc\/mdx323","volume":"28","author":"B Kasper","year":"2017","unstructured":"Kasper B, et al. An update on the management of sporadic desmoid-type fibromatosis: a European Consensus Initiative between Sarcoma PAtients EuroNet (SPAEN) and European Organization for Research and Treatment of Cancer (EORTC)\/Soft Tissue and Bone Sarcoma Group (STBSG). Ann Oncol. 2017;28(10):2399\u2013408.","journal-title":"Ann Oncol"},{"issue":"12","key":"3149_CR6","doi-asserted-by":"publisher","first-page":"1604","DOI":"10.6004\/jnccn.2020.0058","volume":"18","author":"M von Mehren","year":"2020","unstructured":"von Mehren M, et al. NCCN Guidelines insights: Soft tissue sarcoma version 1.2021. J Natl Compr Canc Netw. 2020;18(12):1604\u201312.","journal-title":"J Natl Compr Canc Netw"},{"issue":"5","key":"3149_CR7","doi-asserted-by":"publisher","first-page":"536","DOI":"10.6004\/jnccn.2018.0025","volume":"16","author":"M von Mehren","year":"2018","unstructured":"von Mehren M, et al. Soft tissue sarcoma, Version 2.2018, NCCN Clinical practice guidelines in oncology. J Natl Compr Canc Netw. 2018;16(5):536\u201363.","journal-title":"J Natl Compr Canc Netw"},{"issue":"17","key":"3149_CR8","doi-asserted-by":"publisher","first-page":"2930","DOI":"10.1016\/j.ejca.2009.08.016","volume":"45","author":"A Constantinidou","year":"2009","unstructured":"Constantinidou A, et al. Pegylated liposomal doxorubicin, an effective, well-tolerated treatment for refractory aggressive fibromatosis. Eur J Cancer. 2009;45(17):2930\u20134.","journal-title":"Eur J Cancer"},{"issue":"11","key":"3149_CR9","doi-asserted-by":"publisher","first-page":"1274","DOI":"10.1093\/jjco\/hyaa125","volume":"50","author":"K Shimizu","year":"2020","unstructured":"Shimizu K, et al. Effectiveness of doxorubicin-based and liposomal doxorubicin chemotherapies for patients with extra-abdominal desmoid-type fibromatosis: a systematic review. Jpn J Clin Oncol. 2020;50(11):1274\u201381.","journal-title":"Jpn J Clin Oncol"},{"issue":"10","key":"3149_CR10","doi-asserted-by":"publisher","first-page":"1376","DOI":"10.1016\/j.jvir.2018.04.009","volume":"29","author":"E Elnekave","year":"2018","unstructured":"Elnekave E, et al. Doxorubicin-eluting intra-arterial therapy for pediatric extra-abdominal desmoid fibromatoses: a promising approach for a perplexing disease. J Vasc Interv Radiol. 2018;29(10):1376\u201382.","journal-title":"J Vasc Interv Radiol"},{"issue":"2","key":"3149_CR11","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1097\/SLA.0b013e31828c8a30","volume":"258","author":"AM Crago","year":"2013","unstructured":"Crago AM, et al. A prognostic nomogram for prediction of recurrence in desmoid fibromatosis. Ann Surg. 2013;258(2):347\u201353.","journal-title":"Ann Surg"},{"issue":"13","key":"3149_CR12","doi-asserted-by":"publisher","first-page":"1674","DOI":"10.1002\/bjs.9659","volume":"101","author":"DL van Broekhoven","year":"2014","unstructured":"van Broekhoven DL, et al. Isolated limb perfusion using tumour necrosis factor alpha and melphalan in patients with advanced aggressive fibromatosis. Br J Surg. 2014;101(13):1674\u201380.","journal-title":"Br J Surg"},{"issue":"5","key":"3149_CR13","doi-asserted-by":"publisher","first-page":"568","DOI":"10.1093\/jjco\/hyaa007","volume":"50","author":"T Matsunobu","year":"2020","unstructured":"Matsunobu T, et al. Definitive radiation therapy in patients with unresectable desmoid tumors: a systematic review. Jpn J Clin Oncol. 2020;50(5):568\u201373.","journal-title":"Jpn J Clin Oncol"},{"issue":"9","key":"3149_CR14","doi-asserted-by":"publisher","first-page":"589","DOI":"10.1016\/j.clon.2018.05.002","volume":"30","author":"AM Hong","year":"2018","unstructured":"Hong AM, et al. Radiation therapy as an alternative treatment for desmoid fibromatosis. Clin Oncol (R Coll Radiol). 2018;30(9):589\u201392.","journal-title":"Clin Oncol (R Coll Radiol)"},{"issue":"6","key":"3149_CR15","doi-asserted-by":"publisher","first-page":"e26968","DOI":"10.1002\/pbc.26968","volume":"65","author":"L Agresta","year":"2018","unstructured":"Agresta L, et al. Pazopanib therapy for desmoid tumors in adolescent and young adult patients. Pediatr Blood Cancer. 2018;65(6):e26968.","journal-title":"Pediatr Blood Cancer"},{"issue":"25","key":"3149_CR16","doi-asserted-by":"publisher","first-page":"2417","DOI":"10.1056\/NEJMoa1805052","volume":"379","author":"MM Gounder","year":"2018","unstructured":"Gounder MM, et al. Sorafenib for advanced and refractory desmoid tumors. N Engl J Med. 2018;379(25):2417\u201328.","journal-title":"N Engl J Med"},{"issue":"9","key":"3149_CR17","doi-asserted-by":"crossref","first-page":"2258","DOI":"10.1002\/cncr.25089","volume":"116","author":"VP de Camargo","year":"2010","unstructured":"de Camargo VP, et al. Clinical outcomes of systemic therapy for patients with deep fibromatosis (desmoid tumor). Cancer. 2010;116(9):2258\u201365.","journal-title":"Cancer"},{"issue":"6","key":"3149_CR18","doi-asserted-by":"publisher","first-page":"1500","DOI":"10.1007\/s00270-013-0830-9","volume":"37","author":"M Havez","year":"2014","unstructured":"Havez M, et al. Percutaneous image-guided cryoablation in inoperable extra-abdominal desmoid tumors: a study of tolerability and efficacy. Cardiovasc Intervent Radiol. 2014;37(6):1500\u20136.","journal-title":"Cardiovasc Intervent Radiol"},{"key":"3149_CR19","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1016\/j.ejca.2020.10.035","volume":"143","author":"JE Kurtz","year":"2021","unstructured":"Kurtz JE, et al. CRYODESMO-O1: a prospective, open phase II study of cryoablation in desmoid tumour patients progressing after medical treatment. Eur J Cancer. 2021;143:78\u201387.","journal-title":"Eur J Cancer"},{"issue":"1","key":"3149_CR20","doi-asserted-by":"publisher","first-page":"640","DOI":"10.1245\/s10434-021-10463-7","volume":"29","author":"JE Mandel","year":"2021","unstructured":"Mandel JE, et al. Percutaneous cryoablation provides disease control for extra-abdominal desmoid-type fibromatosis comparable with surgical resection. Ann Surg Oncol. 2021;29(1):640\u20138.","journal-title":"Ann Surg Oncol"},{"issue":"3","key":"3149_CR21","doi-asserted-by":"publisher","first-page":"366","DOI":"10.1002\/jso.25597","volume":"120","author":"K Redifer Tremblay","year":"2019","unstructured":"Redifer Tremblay K, et al. Percutaneous cryoablation for the treatment of extra-abdominal desmoid tumors. J Surg Oncol. 2019;120(3):366\u201375.","journal-title":"J Surg Oncol"},{"issue":"9","key":"3149_CR22","doi-asserted-by":"publisher","first-page":"1277","DOI":"10.1016\/j.jvir.2021.05.025","volume":"32","author":"YY Yan","year":"2021","unstructured":"Yan YY, et al. A single-center 10-year retrospective analysis of cryoablation for the management of desmoid tumors. J Vasc Interv Radiol. 2021;32(9):1277\u201387.","journal-title":"J Vasc Interv Radiol"},{"issue":"2","key":"3149_CR23","doi-asserted-by":"publisher","first-page":"732","DOI":"10.1007\/s00330-016-4376-5","volume":"27","author":"P Ghanouni","year":"2017","unstructured":"Ghanouni P, et al. Magnetic resonance-guided focused ultrasound treatment of extra-abdominal desmoid tumors: a retrospective multicenter study. Eur Radiol. 2017;27(2):732\u201340.","journal-title":"Eur Radiol"},{"issue":"2","key":"3149_CR24","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1007\/s10396-015-0682-9","volume":"43","author":"Y Shi","year":"2016","unstructured":"Shi Y, et al. High-intensity focused ultrasound treatment for intra-abdominal desmoid tumors: a report of four cases. J Med Ultrason (2001). 2016;43(2):279\u201384.","journal-title":"J Med Ultrason (2001)"},{"issue":"3","key":"3149_CR25","doi-asserted-by":"publisher","first-page":"474","DOI":"10.1016\/j.jhep.2006.10.020","volume":"46","author":"M Varela","year":"2007","unstructured":"Varela M, et al. Chemoembolization of hepatocellular carcinoma with drug eluting beads: efficacy and doxorubicin pharmacokinetics. J Hepatol. 2007;46(3):474\u201381.","journal-title":"J Hepatol"},{"issue":"3","key":"3149_CR26","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1097\/00001813-200303000-00008","volume":"14","author":"CE Swenson","year":"2003","unstructured":"Swenson CE, et al. Pharmacokinetics of doxorubicin administered iv as Myocet (TLC D-99; liposome-encapsulated doxorubicin citrate) compared with conventional doxorubicin when given in combination with cyclophosphamide in patients with metastatic breast cancer. Antican Drug. 2003;14(3):239\u201346.","journal-title":"Antican Drug"},{"issue":"3\u20134","key":"3149_CR27","doi-asserted-by":"publisher","first-page":"458","DOI":"10.1016\/j.ejps.2010.07.015","volume":"41","author":"DR Barpe","year":"2010","unstructured":"Barpe DR, Rosa DD, Froehlich PE. Pharmacokinetic evaluation of doxorubicin plasma levels in normal and overweight patients with breast cancer and simulation of dose adjustment by different indexes of body mass. Eur J Pharm Sci. 2010;41(3\u20134):458\u201363.","journal-title":"Eur J Pharm Sci"},{"issue":"3","key":"3149_CR28","doi-asserted-by":"publisher","first-page":"217","DOI":"10.14309\/crj.2016.55","volume":"3","author":"P Nagpal","year":"2016","unstructured":"Nagpal P, et al. Abdominal skin rash after TACE due to non-target embolization of hepatic falciform artery. ACG Case Rep J. 2016;3(3):217\u201320.","journal-title":"ACG Case Rep J"},{"key":"3149_CR29","doi-asserted-by":"publisher","DOI":"10.1136\/bcr-2017-222394","author":"AG Elsayed","year":"2018","unstructured":"Elsayed AG, Martin JM, Pacioles T. Rash and subcutaneous fat necrosis after DEB-TACE with doxorubicin. BMJ Case Rep. 2018. https:\/\/doi.org\/10.1136\/bcr-2017-222394.","journal-title":"BMJ Case Rep"},{"issue":"6","key":"3149_CR30","doi-asserted-by":"publisher","first-page":"2261","DOI":"10.1002\/hep.26256","volume":"57","author":"W Sieghart","year":"2013","unstructured":"Sieghart W, et al. The ART of decision making: retreatment with transarterial chemoembolization in patients with hepatocellular carcinoma. Hepatology. 2013;57(6):2261\u201373.","journal-title":"Hepatology"},{"issue":"4","key":"3149_CR31","doi-asserted-by":"publisher","first-page":"855","DOI":"10.1016\/j.jhep.2014.11.014","volume":"62","author":"X Adhoute","year":"2015","unstructured":"Adhoute X, et al. Retreatment with TACE: the ABCR SCORE, an aid to the decision-making process. J Hepatol. 2015;62(4):855\u201362.","journal-title":"J Hepatol"},{"issue":"4","key":"3149_CR32","doi-asserted-by":"publisher","first-page":"748","DOI":"10.1097\/SLA.0000000000003073","volume":"271","author":"MR Cassidy","year":"2020","unstructured":"Cassidy MR, et al. Association of MRI T2 signal intensity with desmoid tumor progression during active observation: a retrospective cohort study. Ann Surg. 2020;271(4):748\u201355.","journal-title":"Ann Surg"},{"issue":"3","key":"3149_CR33","doi-asserted-by":"publisher","first-page":"767","DOI":"10.1148\/rg.2016150153","volume":"36","author":"M Braschi-Amirfarzan","year":"2016","unstructured":"Braschi-Amirfarzan M, et al. Role of imaging in management of desmoid-type fibromatosis: a primer for radiologists. Radiographics. 2016;36(3):767\u201382.","journal-title":"Radiographics"},{"issue":"5","key":"3149_CR34","first-page":"1377","volume":"27","author":"F Recchia","year":"2012","unstructured":"Recchia F, et al. Chemoembolization of unresectable hepatocellular carcinoma: decreased toxicity with slow-release doxorubicineluting beads compared with lipiodol. Oncol Rep. 2012;27(5):1377\u201383.","journal-title":"Oncol Rep"},{"issue":"2 Pt 1","key":"3149_CR35","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1097\/01.RVI.0000195323.46152.B3","volume":"17","author":"AL Lewis","year":"2006","unstructured":"Lewis AL, et al. DC bead: in vitro characterization of a drug-delivery device for transarterial chemoembolization. J Vasc Interv Radiol. 2006;17(2 Pt 1):335\u201342.","journal-title":"J Vasc Interv Radiol"}],"container-title":["CardioVascular and Interventional Radiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00270-022-03149-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00270-022-03149-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00270-022-03149-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,20]],"date-time":"2023-11-20T01:01:31Z","timestamp":1700442091000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00270-022-03149-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,4,19]]},"references-count":35,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2022,8]]}},"alternative-id":["3149"],"URL":"https:\/\/doi.org\/10.1007\/s00270-022-03149-4","relation":{},"ISSN":["0174-1551","1432-086X"],"issn-type":[{"value":"0174-1551","type":"print"},{"value":"1432-086X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,4,19]]},"assertion":[{"value":"14 December 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 April 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 April 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 May 2022","order":4,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Update","order":5,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"For TABLE 2, author inserted a comment\/explanation on the proof saying \u201cBold values were used just to highlight \u201csignificant\u201d results\u201d, but this comment mistakenly appears in the published article as a legend and should be deleted.","order":6,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Authors disclose no potential financial conflicts regarding the work presented in this article.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and\/or national research committee and with the 1964 Helsinki Declaration and its later amendments or comparable ethical standards. The study was approved by Institutional Review Boards and the informed consent was waived due to the retrospective design. Consent for publication was obtained for every individual person\u2019s data included in the study.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical Approval"}},{"value":"The content of this article has been presented at Cardiovascular and Interventional Radiological Society of Europe (CIRSE) 2021 Summit (September 2021) and Connective Tissue Oncology Society 2021 Annual Meeting (November 2021).","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for Publication"}}]}}